Skip to main content
. 2022 Jan 12;10(4):589–594. doi: 10.14218/JCTH.2021.00311

Fig. 1. Flowchart for the analysis and validation of noninvasive fibrosis scores for predicting advanced fibrosis in MAFLD.

Fig. 1

ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; MAFLD, metabolic associated fatty liver disease; NHANES, National Health and Nutrition Examination Surveys; PLT, platelet count.